Published in Prog Neuropsychopharmacol Biol Psychiatry on January 01, 1987
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Comparison of beclomethasone dipropionate aerosol and prednisolone in reversible airways obstruction. Br Med J (1972) 4.26
A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A (1971) 3.36
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Outpatient termination of pregnancy. Br Med J (1971) 2.60
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Determinants of skeletal muscle catabolism after severe burn. Ann Surg (2000) 2.56
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr (1975) 2.25
Chikungunya fever: a re-emerging viral infection. Indian J Med Microbiol (2008) 2.06
The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci (2000) 2.04
Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine. Indian J Med Microbiol (2005) 2.04
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev (1997) 1.98
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Cardiovascular and respiratory effects of morphine and pentazocine in patients with myocardial infarction. Lancet (1969) 1.95
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
Prolactin, phenothiazines, admission to mental hospital, and carcinoma of the breast. Lancet (1973) 1.80
Polyglutamine-containing proteins in schizophrenia. Mol Psychiatry (1999) 1.77
Psychosocial consequences of therapeutic abortion King's termination study III. Br J Psychiatry (1976) 1.76
Automated detection of diabetic retinopathy on digital fundus images. Diabet Med (2002) 1.69
Epidemiological and clinical features in 165 cases of granuloma inguinale. Br J Vener Dis (1970) 1.65
The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) (1988) 1.63
Efficacy of co-trimoxazole in Donovanosis. A preliminary report. Br J Vener Dis (1978) 1.62
Community studies on prevalence of HBsAg in two urban populations of southern India. Indian Pediatr (2000) 1.62
Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaB-dependent pathways. Arthritis Rheum (2009) 1.60
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci (2000) 1.56
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.55
Nedocromil sodium: a new drug for the management of bronchial asthma. Thorax (1984) 1.51
A strategy to detect beta-thalassaemia minor. Lancet (1977) 1.49
Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.48
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci (1999) 1.47
Intravenous salbutamol and cardiogenic shock. Lancet (1972) 1.46
Follow-up at ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec Screening Program. J Pediatr (1985) 1.46
Preliminary results on the mental development of hypothyroid infants detected by the Quebec Screening Program. J Pediatr (1983) 1.46
Predicting high blood pressure in pregnancy: a multivariate approach. J Hypertens (1998) 1.45
The transmission of information in primary receptor neurones and second-order neurones of a phasic system. J Physiol (1962) 1.44
Modification of a screening program for neonatal hypothyroidism. J Pediatr (1978) 1.44
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci (1999) 1.42
Gene discovery using the maize genome database ZmDB. Nucleic Acids Res (2000) 1.41
Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proc Natl Acad Sci U S A (1981) 1.39
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J Physiol (2003) 1.39
Hazard of yawning. CMAJ (1990) 1.38
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
Comparison of the conventional diagnostic modalities, bactec culture and polymerase chain reaction test for diagnosis of tuberculosis. Indian J Med Microbiol (2005) 1.37
An analysis of the negative inotropic action of somatostatin. Br J Pharmacol (1979) 1.37
Purification of human prolactin. J Biol Chem (1972) 1.37
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst (1990) 1.34
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A (1995) 1.33
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. Anticancer Res (1989) 1.33
Continued efficacy of streptomycin in the treatment of granuloma inguinale. Br J Vener Dis (1971) 1.32
Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A (1994) 1.30
Immunologic evidence for monkey and human prolactin (MPr and HPr). J Clin Endocrinol Metab (1971) 1.30
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem (2000) 1.29
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Res (1974) 1.29
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes (1999) 1.28
Further evidence of the efficacy of co-trimoxazole in granuloma venereum. Br J Vener Dis (1980) 1.28
Acute brucellosis treated with trimethoprim and sulphamethoxazole. Br Med J (1970) 1.26
Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures. Br Heart J (1969) 1.25
Thyroid function in neonatal hypothyroidism. J Pediatr (1976) 1.24
Chronic radiation enteritis. Clin Oncol (R Coll Radiol) (2009) 1.24
Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab (1975) 1.23
Predictors of outcome in acute meningococcal infection in children. Crit Care Med (1993) 1.23
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) (1989) 1.23
Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest (1972) 1.22
Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience (2000) 1.21
An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol. Thorax (1974) 1.21
Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol (1997) 1.20
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol (2000) 1.20
Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience (2005) 1.20
Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience (2002) 1.19
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience (1997) 1.17
Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol (1972) 1.15
TSH measurements from blood spots on filter paper: a confirmatory screening test for neonatal hypothyroidism. J Pediatr (1976) 1.14
Cardiac disease in pregnancy. Int J Gynaecol Obstet (2003) 1.14
Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience (2003) 1.13
Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13
A simple method for the study of yawning in man induced by the dopamine receptor agonist, apomorphine. Prog Neuropsychopharmacol Biol Psychiatry (1987) 1.13
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol (2000) 1.12
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol (1993) 1.12
Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience (2005) 1.11
Implementing the revised International Health Regulations in India. Natl Med J India (2008) 1.11
T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci (1999) 1.10
Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev (1995) 1.10
Biosynthesis of monkey growth hormone and prolactin in vitro. Endocrinology (1971) 1.10
Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Res (1998) 1.10
The Indian Ocean experiment: widespread air pollution from South and Southeast Asia. Science (2001) 1.09
Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol (1998) 1.08
Diagnostic potential of IS6110, 38kDa, 65kDa and 85B sequence-based polymerase chain reaction in the diagnosis of Mycobacterium tuberculosis in clinical samples. Indian J Med Microbiol (2007) 1.08
Esophageal motility in tracheoesophageal fistula and esophageal atresia. Surg Gynecol Obstet (1966) 1.08
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08